Venesection

Reading File
Finding Sources
Finding Sources
Searching the Web

venesection phlebotomy indications procedure clinical

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
I now have sufficient textbook content to write a comprehensive answer. Let me compose it.

Venesection (Therapeutic Phlebotomy)

Venesection (also called therapeutic phlebotomy or bloodletting) is the deliberate removal of a volume of blood — typically 450–500 mL per session — for therapeutic purposes. It is distinct from diagnostic phlebotomy (blood drawing for tests).

Indications

1. Hereditary Haemochromatosis (HH)

The primary and most important indication. HH is an autosomal-recessive disorder (>80% due to the HFE C282Y homozygous mutation) causing excessive intestinal iron absorption due to inappropriately low hepcidin expression. Iron accumulates in the liver, pancreas, heart, pituitary, skin, and joints, causing:
  • Cirrhosis → hepatocellular carcinoma (200× increased risk)
  • Diabetes mellitus (pancreatic islet destruction)
  • Bronze skin pigmentation
  • Cardiomyopathy/arrhythmias
  • Hypogonadism, arthritis
Treatment: Regular phlebotomy steadily depletes tissue iron stores. With treatment, life expectancy is normal — Robbins, Cotran & Kumar, p. 813.
Protocol:
  • Induction phase: 500 mL every 1–2 weeks until serum ferritin reaches low-normal range
  • Maintenance phase: Every 2–3 months to keep ferritin ~50–100 µg/L
  • Monitor: serum ferritin (primary target); TSAT monitoring during maintenance is not recommended as it fluctuates widely — Tietz Textbook of Laboratory Medicine, p. 1381
  • Prerequisites: Hb >120 g/L, serum ferritin >25 µg/L, stable BP and pulse, adequate venous access, recent oral intake

2. Polycythaemia Vera (PV)

PV is a JAK2-mutant myeloproliferative neoplasm causing excess red cell production. Elevated haematocrit increases blood viscosity and thrombotic risk.
  • Target: Haematocrit <45% (reduces thrombotic and cardiovascular events)
  • Phlebotomy is first-line in low-risk PV; cytoreduction with hydroxyurea or ropeginterferon-alfa-2b is added in high-risk patients
  • Ropeginterferon-alfa-2b achieves haematocrit <45% in ~85% vs ~60% with phlebotomy alone — Goldman-Cecil Medicine, p. 1756
  • Ruxolitinib (JAK1/2 inhibitor) is used when phlebotomy-dependent PV is inadequately controlled on hydroxyurea
  • Note: Iron supplementation is contraindicated in PV patients undergoing phlebotomy (iron deficiency suppresses erythropoiesis and helps maintain control)

3. Porphyria Cutanea Tarda (PCT)

PCT causes a blistering photosensitivity dermatosis due to impaired uroporphyrinogen decarboxylase activity; iron overload is a major precipitant.
  • 500 mL venesection every 2 weeks until serum ferritin reaches low-normal range
  • Typically requires 8–12 sessions to achieve remission
  • Alternative/adjunct: oral chloroquine 125 mg twice weekly (releases porphyrins renally)
  • Patients with anaemia (e.g., renal failure) may need concurrent erythropoietic agents — Goldman-Cecil Medicine, p. 1569

4. Chronic Mountain Sickness (Monge Disease)

At high altitude, chronic hypoxia drives extreme erythrocytosis. Venesection ± isovolumetric haemodilution is used widely when relocation to lower altitude is not possible — Miller's Anaesthesia, p. 3019.

5. Other (historical/emerging)

  • Secondary haemochromatosis (thalassaemia, myelodysplastic syndrome) — phlebotomy generally avoided if anaemia present; iron chelation preferred
  • Non-HFE haemochromatosis — same phlebotomy approach as HFE-HH

Procedure

StepDetail
Volume450–500 mL per session
AccessAntecubital fossa, 16–18G needle; alternate arms between sessions
EquipmentStandard blood donor bag with tubing, tourniquet, BP monitor, scales
Duration~15–30 minutes
FluidsAdequate oral hydration pre-procedure; patient should not be fasting

Contraindications / Prerequisites

  • Hb <120 g/L (anaemia)
  • Systolic BP <110 or >160 mmHg; diastolic <60 or >95 mmHg
  • Pulse <50 or >100 bpm
  • Serum ferritin <25 µg/L (in HH maintenance)
  • Poor venous access
  • Fasting state

Complications

ComplicationNotes
Vasovagal syncopeMost common; lie patient flat, raise legs
HaematomaAt venepuncture site
HypovolaemiaEspecially in elderly or cardiovascular disease
Phlebitis / venous scarringWith repeated sessions
Iron-deficiency anaemiaIf phlebotomy is excessive

Monitoring Parameters

ConditionPrimary MonitorTarget
HH (induction)Serum ferritinLow-normal range
HH (maintenance)Serum ferritin50–100 µg/L
PVHaematocrit<45%
PCTSerum ferritinLow-normal range

Mechanism of Benefit

Each 500 mL unit of blood contains approximately 200–250 mg of iron (haemoglobin carries ~0.5 mg Fe/mL of red cells). Repeated venesection depletes total body iron stores without drug-related toxicity. The body compensates with increased erythropoiesis, which in turn scavenges iron from storage depots — Medical Physiology, p. 1241.

Sources: Robbins, Cotran & Kumar – Pathologic Basis of Disease | Goldman-Cecil Medicine | Medical Physiology | Tietz Textbook of Laboratory Medicine | Miller's Anaesthesia | Emery's Elements of Medical Genetics
This is a shared conversation. Sign in to Orris to start your own chat.